What Complement Technology does

Complement Technology is a privately held, small-scale life sciences reagent supplier founded in 2005 and based in Tyler, Texas. The company sells purified proteins, polyclonal antisera, animal proteins, and depleted sera—specialized research reagents. The product mix (matched with the company name) is consistent with reagents used in complement-system research, which is a technically demanding niche within immunology and inflammation biology. Typical end users are academic complement-research laboratories, pharmaceutical groups working on complement-targeted therapeutics, and diagnostics developers building complement-related assays.

The company's catalog centers on three reagent categories that are interdependent in complement-system workflows. Purified complement proteins are used as standards and assay components; polyclonal antisera serve as detection reagents in immunoassays, hemolysis assays, and Western blot workflows; animal proteins and depleted sera are used as experimental controls and matrix backgrounds. These categories are tightly coupled technically, and supplying them as a coherent set is a meaningful operational decision.

With 1-10 employees, Complement Technology operates as a focused specialty supplier rather than a diversified life sciences distributor. Specific business model details (pricing structure, distribution channels, customer segments, average order size, and revenue mechanics) are not disclosed in the available source material. The company's website (complementtech.com) returned only a verification/loading page during data collection, restricting visibility into commercial terms, marketing approach, and leadership. No funding rounds, M&A activity, leadership changes, product launches, partnerships, or regulatory actions are documented in the available data.

Name

Complement Technology

Website

https://complementtech.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Complement Technology is a privately held specialty life sciences supplier based in Tyler, Texas, founded in 2005, providing purified proteins, polyclonal antisera, animal proteins, and depleted sera to complement-system researchers.

Ownership category

akta.pro rank

Product category

Life Sciences Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Complement reagents
• Purified proteins
• Polyclonal antisera
• Depleted sera
• Immunology research

Headquarters

HQ city

Tyler

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D

Core offering

Complement Technology sells purified proteins, polyclonal antisera, animal proteins, and depleted sera. These biological reagents support immunology and complement-system research applications for academic, clinical, and pharmaceutical research customers.

Differentiator

Problem solved

Functional benefit

Products and services

• Purified Proteins Complement-system proteins purified for use in immunology and complement-biology research applications; intended for research laboratories studying complement pathways.
• Polyclonal Antisera Polyclonal antibody preparations directed against complement-system proteins, provided for research use in immunology assays and complement-protein detection.
• Animal Proteins Animal-derived proteins supplied for use in research applications related to complement-system and immunology studies.
• Depleted Sera Sera with specific complement components removed, supplied to research laboratories for assays where endogenous complement activity must be abrogated.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Lee Biosolutions: Lee Biosolutions is a US-based manufacturer of human and animal plasma proteins, sera, and related biochemical reagents used in research and diagnostics. It is a direct peer because it competes with Complement Technology in supplying purified proteins and specialty sera to complement and immunology researchers.
• Hycult Biotech: Hycult Biotech is a Netherlands-based specialist in innate immunity and complement system reagents, offering complement proteins, antibodies, and assay kits. It is a direct peer because its core catalog (complement proteins, depleted sera, polyclonal antibodies) overlaps almost entirely with Complement Technology's offerings for the same research end users.
• Athens Research and Technology: Athens Research and Technology, based in Georgia, US, manufactures purified human plasma proteins — including complement components — and related immunological reagents for research use. It is a direct peer because it competes head-to-head with Complement Technology in supplying purified complement proteins to academic and industrial researchers.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher Scientific supplies immunology and protein research reagents — including complement-related antibodies and proteins — through its Invitrogen, Thermo Scientific, and Pierce brands. It is a broad incumbent whose scale, catalog, and distribution make it the dominant alternative for complement research customers.
• Cytiva (Danaher): Cytiva, part of Danaher, supplies proteins, antibodies, and cell biology reagents to life science researchers worldwide. It is a broad incumbent whose catalog competes for the same immunology and protein-research budget that Complement Technology serves, though Cytiva is not specialized in the complement niche.
• Abcam: Abcam is a major global supplier of research-grade antibodies and immunological reagents, including products targeting complement components. It is a broad incumbent competing for the same complement-research customers as Complement Technology but from a much larger catalog and global distribution footprint.
• Bio-Rad Laboratories: Bio-Rad is a global life science research and clinical diagnostics company that sells a broad portfolio of antibodies, proteins, ELISA kits, and immunology reagents, including complement-related products. It is a broad incumbent that competes with Complement Technology across multiple reagent categories but does not specialize in the complement niche.
• QuidelOrtho: QuidelOrtho is a US-based diagnostics and life sciences company that develops immunoassays, complement diagnostic tests (e.g., CH50, AH50), and specialty reagents. It is a broad incumbent that operates in the complement reagent space from a diagnostic-testing angle, adjacent to but overlapping with Complement Technology's research-reagent business.
• Merck (Sigma-Aldrich / MilliporeSigma): Merck's life science tools business sells a vast catalog of proteins, antibodies, sera, and lab reagents through the Sigma-Aldrich and MilliporeSigma brands, including complement-system products. It is a broad incumbent whose offering overlaps with Complement Technology but whose scale and breadth dwarf the niche specialist.

Emerging players

• Calbiotech / Eagle Biosciences: Calbiotech and Eagle Biosciences are US-based specialty immunoassay and ELISA kit developers with a meaningful focus on complement pathway research reagents. They are emerging players with partial overlap — competing with Complement Technology for complement researchers while leaning more into finished kits than bulk proteins.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/complement-technology-inc.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Complement Technology